Autifony Therapeutics shortlisted in top five biotech SMEs in Europe by EuropaBio

Autifony Therapeutics Limited (“Autifony”), which is pioneering the development of novel pharmaceutical treatments for hearing disorders, today announced that it has been selected by EuropaBio as one of the top five biotech SMEs in Europe, who will compete to win the 5th annual Most Innovative EU Biotech SME Award.

Read More